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Few studies have evaluated iron-rich plant-based foods, such as amaranth grain, to reduce
anemia and iron deficiency anemia. Amaranth is rich in nutrients, but with high level of phy-
tate. The objective of this trial was to evaluate the efficacy of home processed amaranth
grain containing bread in the treatment of anemia, hemoglobin concentration and iron defi-
ciency anemia among two-to-five year-old children in Southern Ethiopia.
Method
Children with anemia (hemoglobin concentration <110.0g/L) (N = 100) were identified by
random sampling and enrolled in a 1:1 cluster randomized controlled trial for six months in
2017. The amaranth group (N = 50), received 150g bread containing 70% amaranth and
30% chickpea, the amaranth grain was processed at home (soaking, germinating, and fer-
menting) to decrease the phytate level. The maize group (N = 50), received 150g bread,
containing processed maize (roasted and fermented) to give a similar color and structure
with amaranth bread. Hemoglobin, ferritin, and CRP were measured at baseline and at the
end of intervention. Hemoglobin and ferritin values were adjusted for altitude and infection,
respectively. Generalized estimating equation and generalized linear model were used to
analyze the data.
Result
In the last follow-up measure anemia prevalence was significantly lower in the amaranth
group (32%) as compared with the maize group (56%) [adjusted risk ratios, aRR: 0.39 (95%
CI: 0.16–0.77)]. Hemoglobin concentration estimate of beta coefficient was significantly
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higher in the amaranth group compared with the maize group [aβ 8.9g/L (95%CI: 3.5–
14.3)], p-value <0.01. The risk of iron deficiency anemia is significantly lower in the ama-
ranth group [aRR: 0.44 (95%CI: 0.23–0.83)] in the intention to treat analysis but not signifi-
cant in the complete case analysis. There was no significant difference between groups in
iron deficiency [aRR: 0.81 (95%CI: 0.55–1.19)].
Conclusion
Processed amaranth bread had favorable effects on hemoglobin concentration and has the
potential to minimize anemia prevalence.
Clinical trial registration
Trial registry number: PACTR201705002283263 https://pactr.samrc.ac.za/TrialDisplay.
aspx?TrialID=2283
Introduction
Chronic malnutrition is a leading health problem among children under five years of age in
Ethiopia [1]. Anemia is a chronic type of malnutrition and a major contributor to childhood
morbidity and mortality, limited physical and cognitive development, and decreased produc-
tivity later in life. In Ethiopia, 57% of children under five years old suffer from anemia [2]. The
major cause of anemia is inadequate intake of micronutrients, mainly iron containing foods.
These nutrients are largely found in animal-source food, which is generally unaffordable for
families living in poverty. The staple food comprising the vast amount of energy in the diet of
Ethiopians is dominated by starchy cereals, which are low in proteins, minerals, and vitamins
[2].
Studies indicate that the amaranth plant has the potential to reduce food insecurity and
resultant undernutrition [3,4]. Amaranth is a pseudo-cereal with high grain yield and capable
of withstanding extreme climate and soil conditions. Amaranth also possesses good nutritional
qualities with a high level of protein, minerals, and fat as compared to commonly utilized cere-
als, such as maize. Amaranth grain contains 16/100 grams (g) protein, 173 milligrams (mg)/
100 g calcium, 35 mg/100 g iron, 3 mg/100 g zinc, and higher potassium, phosphorous, magne-
sium, manganese, vitamins A and E, and folic acid levels than cereal grains [5,6]. Conse-
quently, it can constitute a cheaper alternative for poor households to address nutritional
anemia.
Even though amaranth contains quality amino-acids, high iron and other micro-nutrients,
it also has a high concentration of phytic acid that can reduce the bio-availability of nutrients,
especially iron, protein, and zinc [6,7]. One study from Kenya indicated that amaranth has no
significant effect on the anemia and iron status of children, and this could be due to a high
iron to phytate molar ratio [6]. However, prior to this study, research had been performed on
methods to decrease the phytate level of amaranth grain by utilizing home processing, such as
soaking, germinating, and fermenting, using locally available materials to create acidic media.
The research identified methods to decrease phytate level to an acceptable level of iron to phy-
tate molar ratio of less than one [8,9] but its effectiveness has not yet been investigated in vitro.
Thus, the present study aimed to evaluate the efficacy of processed amaranth grain compared
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to the commonly consumed maize on hemoglobin concentration and on treatment of anemia
prevalence among two-to-five year-old children in Southern Ethiopia.
Methods
Ethics approval and consent to participate
The Institutional Review Board of Hawassa University (IRB/098/08) provided ethical approval
on September 06, 2016 and the Regional Ethical Committee West of Norway (No. 2016/2034)
on December 15, 2016. Local administrative and health post authorities also granted official
permissions for the study. Informed written consent was obtained from the mothers. The trial
was registered (Pan African Clinical Trials Registry number: PACTR201705002283263). The
authors confirm that all related trials for this food were registered.
The justification for delayed trial registration was a delay we faced when trying to register it
at ClinicalTrial.gov. After getting the ethical approval, we immediately applied for the registra-
tion of the Clinical Trials on February 6, 2017, to ClinicalTrial.gov. Their response was unfor-
tunately delayed, and we therefore dropped it on May 11, 2017. Then, we applied to Pan
African Clinical Trial Registry (PACTR) on May 11, 2017 and shortly afterwards; we got the
trial registration on May 19, 2017. During the time, we started the survey to maintain the
study schedule. After the survey, we identified children with anaemia which required immedi-
ate interventions as per the ethical approval agreement.
Protocol available
Protocol will be available after publication at: https://dx.doi.org/10.17504/protocols.io.
bhzbj72n.
Study area
The study was carried out in the Cheffe Cotte Jebessa kebele (lower administrative unit), in the
suburban parts of Hawassa city, in southern Ethiopia. The altitude of the study area ranges
from 1708 to 1920 meters above sea level. The annual average temperature is 12–27˚C with an
average rainfall of 500 to 1,800 millimeter. The main crops cultivated in the area include
maize, haricot beans, enset, and Irish potatoes. Amaranth grows as a wild crop in the study
area, and its grains and leaves are used as food. Furthermore, the grain part is utilized for both
medicinal purposes and alcoholic beverage production in the study area and other parts of the
country.
Study design
The study design was a community-based food intervention with a 1:1 cluster randomized
controlled trial.
Sample size
Prior to the trial, a census was conducted and 1689 children two-to-five year-old were identi-
fied in the study area. By using simple random sampling we selected 340 children and a cross-
sectional study carried out to identify children with mild and moderate anemia. The sample
size of 340 was estimated to identify anemic children, assuming a 33% mild and moderate ane-
mia prevalence in South Ethiopia, precision of 0.5, and 95% confidence intervals. The sample
size of the trial was calculated considering a mean difference of 0.7 in hemoglobin level [10], 1
standard deviation, power of 90%, alpha level of 0.05 with two sided test and an attrition rate
of 12%. The total sample size of the trial was 100, with 50 children in each arm.
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We conducted the survey from February 15, to March 30, 2017 and identified 100 children
with anemia. The identified children were sparsely distributed in the study area and thus, we
clustered them in to eight clusters by their geographic locations to ease the distribution of
breads and for close follow-up. The eight clusters were randomly allocated into four clusters in
the maize arm and four clusters in the amaranth arm, and each arm had 50 children. The ran-
dom allocation was done by external body without knowing about the cluster. Then, the inter-
vention (feeding of breads) was started for both arms on April 14, 2017 and continued for the
next six months.
Inclusion and exclusion criteria
Caregiver-child pairs were included in the study, in which the mother was the targeted respon-
dent. The children included in the study were two-to-five year-olds with hemoglobin levels
from 70 to<110 g/L, who lived in the area, and planned to live in the area for the next one
year. Children were excluded if they were living with chronic illnesses, such as HIV/AIDS,
tuberculosis, or cancer. Children who were taking iron supplements, received a blood transfu-
sion in the last six months, had repeated malaria at least three times in the last three months,
or were unwilling to participate in the study were also excluded.
Outcome variables
The primary outcome was hemoglobin concentration and anemia prevalence, and the second-
ary outcome was iron deficiency anemia and iron deficiency.
Intervention
In both groups, the intervention and the control, 150 g bread was provided to the children
under the researcher team’s supervision on a daily basis for the period of six months. The chil-
dren in the experimental and control groups labelled ‘amaranth group’ and ‘maize group’,
respectively. The amaranth group was supplied with bread containing 70 mass % amaranth
grain and 30 mass % mashed chickpea. The maize group was supplied with the same size of
bread containing 100% maize. All participants in the amaranth and maize groups were treated
with albendazole 400 mg single dose, irrespective of their last dosage prior to the start of the
feeding intervention and at the end of feeding intervention.
Recipe preparation
Home level processing was applied to the amaranth grain to reduce phytate level. Amaranth
grain was soaked in water by adding 5 ml of lemon juice per 100 ml of water for 24 hours and
germinated for 72 hours. After sun drying, it was roasted and milled with a local electrical mill
then fermented bread was prepared [9]. At the same time, maize grain was also roasted and
fermented in order to make the recipe similar in color and structure with amaranth bread. The
recipe was prepared based on the recommended dietary allowance (RDA); according to RDA,
150 g of bread (70% amaranth with 30% chickpea) had 22.3 mg of iron contained in the bread,
which can fulfill 50% of RDA considering 15–20% iron absorption. The acceptability of this
combination was tested in the community in the previous study and it was acceptable [9,10]
“Table 1”.
Distribution and masking
The study participant, bread distributer, and data collector were uninformed about arm alloca-
tion and the content of the bread. Both grains, amaranth and maize, were processed (roasted
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and fermented) to make the bread similar in color and structure. The bread distributers were
different for the amaranth and maize arms, and there were eight caregivers, one for each clus-
ter. Eight boxes, one for each cluster, were packed and labeled with the respective caregiver’s
name. Each caregiver feed the child at their home every day under her direct supervision. In
case of refusals or absenteeism, unopened bread was returned and registered at coordinator
level each day.
Blood collection and laboratory methods
Three to five milliliter (ml) of venous blood was collected in test tubes with lithium heparin
plasma to measure hemoglobin, serum ferritin, and CRP at the scheduled baseline and last fol-
low-up visits. Hemoglobin concentration was determined immediately using a HemoCue ana-
lyser 301 (Angelholm, Sweden). All samples with hemoglobin <110 g/L were tested further for
serum-ferritin and CRP. Anemia was classified based on altitude-adjusted hemoglobin con-
centration as normal (�110.0 g/L), mild (100.0–109.0 g/L), moderate (70.0–99.0 g/L), or severe
(<70.0 g/L) [11,12]. Children with severe anemia (<70.0 g/L) identified in the survey were
excluded from the trial, as they were referred for medical treatment (N = 1). Hemoglobin con-
centrations were corrected for altitudes, according to WHO standards [11,12].
Serum ferritin was analyzed using the Cobas 6000 e601 and CRP using the Cobas 6000 c501
module, both from Roche (Germany). Ferritin was adjusted for inflammation based on CRP
measure. The inflammatory state of each individual was classified as “healthy” if CRP<5mg/L
and “with inflammation” if CRP >5mg/L. The cut-off value for ferritin level was set at<12 μg/
L for those children who had CRP<5mg/L (healthy) and<30 μg/L for those children who had
CRP >5mg/L (inflammation). Iron deficiency defined as ferritin concentration <12 μg/L for
healthy children and <30 μg/L for children with inflammation [13,14]. Iron deficiency anemia
was defined as anemia with concurrent iron deficiency [14,15].
Anthropometry measurements
Anthropometric weight and height were measured to assess nutritional status. Height was
measured using a Seca 213 height board (Hamburg, Germany) with a sliding head piece while
the child stood straight. Weight was taken using a calibrated Seca 874 electronic flat scale with
the child barefoot and wearing light clothing. Anthropometry measurements were analysed
according to the Emergency Nutrition Assessment for SMART software 2011 (Toronto, Can-
ada), developed using WHO child growth standards [16]. Weight and height measurements
were converted to height-for-age (HAZ), weight-for-age (WAZ), and weight-for-height
(WHZ) z-scores, based on WHO reference standards. For WHZ, a z-score<-2 indicated wast-
ing,�- 2 to<2 indicated normal, and>2 indicated overweight. For HAZ, a z-score<-2 indi-
cated stunting, and>-2 indicated normal height. WAZ scores<-2 indicated underweight, and
>-2 indicated normal. Moderate and severe undernutrition were defined as z-scores <-2 and
<-3, respectively [17].
Table 1. The nutrient content of amaranth and maize bread.
100 g Protein mg/100g Fat mg/100g Iron mg/100g Calcium mg/100g Zinc mg/100g Energy Kcal
100% maize 7.58 4.44 4.31 24.82 2.47 386
70% amaranth and 30% chickpea 16.39 7.08 15.16 244.71 2.59 404
mg, milligram; g, gram; Kcal, kilocalorie.
https://doi.org/10.1371/journal.pone.0239192.t001
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Questionnaire
A 7 days structured food-frequency questionnaire (FFQ) and 24-hour dietary diversity ques-
tionnaire were used to collect information about children’s diets. The foods were counted in
nine food groups (items), in which the food-frequency items were created based on Food and
Agriculture Organization (FAO) guidelines. The scores ranged from low (<3 food items),
medium (4–5 food items), to high (�6 food items) [18]. Dietary diversity and iron rich food
(red meat, organ meat and fish) 7 days frequency was assessed every month to control con-
founding. The household food diversity scale was categorized into 12 food types, according to
the Food and Nutrition Technical III project, and the answers were scored the same as for the
food-frequency items [18]. We used a household food insecurity measure validated in Ethiopia
by Gebreyesus [19]. The prevalence of household food insecurity was determined using the
nine-component Household Food Insecurity Access Scale (HFIAS). Based on component
scores (1 = rarely, 2 = sometimes, 3 = often), household food insecurity was classified as secure,
mild, moderate, or severe [20].
Statistical analysis
Data were double-entered and checked using EpiData v. 3.1 (Odense, Denmark), and trans-
ferred to IBM SPSS v. 20 (Chicago, IL, U.S.A.) and STATA 15 for analysis [21]. Descriptive sta-
tistics, including frequency counts and percentages, were used to summarize the data and chi-
square test was used to compare the distribution of categorical variables in the amaranth and
maize groups. Means, medians, confidence intervals (CI), and inter quartile ranges (IQR) were
used to summarize continuous variables. Before multivariate analysis was performed, we
checked for baseline differences of anemia, hemoglobin, and ferritin distributions between the
study groups. Intra class correlation coefficients (ICC) was checked prior to running the multi-
variate analysis among the groups’ 1:1 randomly allocated eight clusters: four clusters in the
amaranth group and four clusters in the maize group. There was no significant intra class cor-
relation for anemia, hemoglobin, and ferritin among group clusters (S1 Table).
Intention-to-treat analysis and complete case analysis were used to manage the missing
value of main variables: hemoglobin, ferritin, and CRP (anemia, Iron deficiency anemia and
iron deficiency). Intention-to-treat analysis (ITT) applied by replacing the missing values of
the last follow-up measure from the baseline and a complete-case analysis was restricted to
available information at the last follow-up measure was used to decrease miss-interpretation.
A bivariate and multivariate generalized liner model for binomial family was used for anemia
prevalence. Generalized estimating equations (GEE) procedure was used for analysis of
repeated measurements (hemoglobin, ferritin and CRP) once at baseline and once at last fol-
low up. Hemoglobin was not normally distributed and included as continuous variable.
Adjusted ferritin with CRP was used to categorize iron deficiency anemia and iron deficiency
so that it was included as categorical variable. Quasi likelihood under independency model cri-
teria (QIC) with the lowest value was used to select correlation matrix. Child age, child sex,
dietary diversity and stunting were included in the multivariate analysis. The estimate of beta
coefficient with confidence interval was reported for continuous variables and relative risk
ratio was presented for the categorical variables with confidence interval.
Results
Trial participants
Out of the 100 children in the trial, 82 children remained in the trial cohort at the end of the
scheduled visits, 41children in the amaranth group and 41children in the maize group “Fig 1”.
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There was no statistically significant difference were found in socio-demographic characteris-
tics between discontinued (n = 18) and participated children at last follow-up measure
(P>0.05) “S2 Table”. The six months daily attendance of children with regard to bread con-
sumption indicated that there was no significant mean difference between amaranth and
maize groups [-5.32 (95% CI,-20.1; 9.5)] with P-value > 0.5 “Table 2”.
Fig 1. Trial profile.
https://doi.org/10.1371/journal.pone.0239192.g001
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Baseline characteristics of children
From the hundred participants, half were girls and the mean age was 37 months (95% CI:
34.8–39.1). Majority 73 (73%) of children scored the lowest dietary diversity and 4 (4%) were
scored high dietary diversity. Child illness history indicated that 38 (38%) had a history of
watery diarrhea in the past 15 days preceding the survey. Regarding the nutritional status of
the children, 53 (53%) were stunted, and 28 (28%) were underweight. Stunting prevalence was
significantly higher in the amaranth arm 31/50 (62%) than in the maize group 22/50 (44%)
“Table 3”.
Baseline characteristics of mother and household
All caregivers were mothers, and their median age was 26 (IQR: 24–30) years. The median
completed school years by mothers were 4 (IQR: 0–7) years and 63 (63%) of the mothers were
unemployed. Majority 77 (77%) of the households were earned less than 1.9 USD per day, and
69 (69%) of the households were food insecure “Table 4”.
Magnitude of anemia and iron deficiency anemia at baseline
From the total children with anemia, 29/100 (29%) were moderately anemic and 71/100 (71%)
were mildly anemic. Children with moderate anemia were 38% in amaranth group and 20% in
maze group. Iron deficiency anemia constitutes 30% of the total anemia cases and distributed
as 35% in the amaranth group and 24% in the maize group “Table 5”.
24 hours dietary diversity score
The mean dietary diversity score (DDV) indicated that there was no significant difference
between amaranth and maize arms for each month “Table 6”.
Six month follow-up of iron-rich food consumption
Seven days food frequency recall indicated that 59% of children’s were not consumed iron-
rich food at least one time for the last six consecutive months follow up. There is no significant
difference between groups on iron-rich food consumption (p-value >0.5) “Table 7”.
The effect of amaranth containing bread on anemia prevalence
At last follow-up measure, the overall prevalence of anemia decreased to 44% as compared
with 100% at baseline. Intention-to-treat analysis indicated that, children who received ama-
ranth containing bread had 61% significant reduction in the risk of anemia compared to those
who received maize bread [aRR: 0.39 (95%CI: 0.16–0.77)]. The prevalence of anemia was sig-
nificantly lower (32%) in the amaranth group as compared with the maize group (56%) Simi-
larly, the complete-case analysis result indicated a significant decrease of anemia prevalence in
amaranth group (17%) as compared with (46%) in the maize group [aRR: 0.18 (95%CI: 0.05–
0.57)], “Table 8”.
Table 2. Mean of bread consumption attendance between groups.
Six month children attendance Mean (CI) Mean difference (CI)e P-value
Maize group 146.9 (135.1–158.6) -5.32 (-20.1;9.5) 0.5
Amaranth group 152.2 (142.9–161.5)
https://doi.org/10.1371/journal.pone.0239192.t002
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The effect of amaranth bread on hemoglobin concentration
Last follow-up measure indicated that hemoglobin concentration was increased in both ama-
ranth and maize arms when compared with the baseline results. The estimate of beta coeffi-
cient indicated that children who received amaranth bread had significantly higher amount of
hemoglobin concentration than maize bread, as the 95% CI does not contain zero [aβ 8.9 g/L
(95%CI: 3.5–14.3)] “Table 9”.
The effect of amaranth bread on iron deficiency anemia
The overall prevalence of iron deficiency anemia decreased from 29% at baseline to 18% at last
follow-up measure. Intention to treat analysis showed that iron deficiency anemia risk was sig-
nificantly decreased in the amaranth group from 35% at baseline to 15% at the last follow-up
[aRR: 0.44 (0.23–0.83)]. However, this difference was not significant in the complete case anal-
ysis “Table 10”.
Table 3. Baseline characteristics of children, maize and amaranth groups.
Characteristics Total N = 100 Maize Amaranth
Child age month (mean (CI) (Continuous) 36.9 (34.8–39.1) 36.6 (33.3–39.8) 37.7 (34.9–40.5)
Categorical data N (%)� N = 50; N (%)� N = 50; N (%)�
Child sex
Boy 50 (50) 22 (44.0) 28 (56.0)
Girl 50 (50) 28 (56.0) 22 (44.0)
Diarrhea in the past 15 days
No 62 (62.0) 32 (64.0) 30 (60.0)
Yes 38 (38.0) 18 (36.0) 20 (40.0)
Cough in the past 15 days
No 76 (76.0) 37 (74.0) 39 (81.3)
Yes 22 (22.0) 13 (26.0) 9 (18.8)
Missing 2 (2.0)
Hospital admission since birth
No 88 (88.0) 43 (86.0) 45 (90.0)
Yes 12 (12.0) 7 (14.0) 5 (10.0)
Child dietary diversity
Low 73 (73.0) 38 (77.6) 35 (71.4)
Medium 21 (21.0) 10 (20.4) 11 (22.4)
High 4 (4.0) 1 (1.0) 3 (3.1)
Missing 2 (2.0)
Height for age (HAZ)
No stunting 47 (47.0) 29 (58.0) 18 (36.0)
Stunting 53 (53.0) 22 (42.0) 31 (64.0)
Weight for height (WHZ)
Normal 89 (89.0) 44 (95.7) 45 (88.0)
Wasting 4 (4.0) 1 (2.1) 3 (6.0)
Overweight 4 (4.0) 1 (2.1) 3 (6.0)
Weight for age (WAZ)
Normal 72 (72.0) 38 (76.0) 34 (68.0)
Underweight 28 (28.0) 12 (24.0) 16 (32.0)
https://doi.org/10.1371/journal.pone.0239192.t003
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The effect of amaranth bread on iron deficiency
In the amaranth group iron deficiency was decreased, from 34% at baseline measure to 26% at
last follow-up measure. But the risk of iron deficiency had no significant difference between
groups [aRR: 0.81(0.55–1.19)] “Table 11”.
Discussion
Research on the nutritional value of amaranth and methods to decrease phytate level has been
performed [8,9]. However, few investigations exist focusing on the effect of processed ama-
ranth in vitro. This study is the first in Ethiopia to assess the effect of homemade processed
amaranth grain on the hemoglobin concentration, anemia and iron deficiency anemia status
of children two-to-five years-old.
The findings indicated that hemoglobin concentration increased and the prevalence of ane-
mia decreased significantly after intervention. The mean hemoglobin concentration change
Table 4. Baseline characteristics of mother and households.
Characteristics Total N = 100 Maize Amaranth
Mother age (Continuous) median (IQR) 26 (20–32) 26 (19–31) 26 (20–32)
Categorical data N (%)� N = 50; N %)� N = 50; N (%)�
Mother’s occupation
Unemployed 63 (63.0) 32 (64.0) 31 (62.0 )
Day laborer 23 (23.0) 10 (20.0) 13 (26.0)
Government 14 (14.0) 8 (16.0) 6 (12.0)
Father’s occupation
Unemployed 12 (12.0) 7 (14.0) 5 (10.0)
Daily laborer 49 (49.0) 20 (40.0) 29 (58.4)
Government 39 (39.0) 23 (46.0) 16 (32.0)
Electricity access
No 27 (27.0) 13 (26.0) 14 (28.0)
Yes 73 (73.0) 37 (74.0) 36 (72.0)
Household food security
Food secure 31 (31.0) 15 (30.0) 16 (32.0)
Mild food-insecurity 14 (14.0) 6 (12.0) 8 (16.0)
Moderate food-insecurity 18 (18.0) 10 (20.0) 8 (16.0)
Severe food-insecurity 37 (37.0) 19 (38.0) 18 (36.0)
Household income per month
<1500 (1.9 dollars per day) 77 (77.0) 35 (71.4) 42 (85.7)
>1500 (1.9 dollars per day) 21 (21.0) 14 (28.6) 7 (14.3)
Missing 2 (2.0)
https://doi.org/10.1371/journal.pone.0239192.t004
Table 5. Magnitude of anemia and iron deficiency anemia distribution between groups.
Maize N (%) Amaranth N (%) Total N (%)
Iron deficiency anemia N = 91
Yes 11 (24.4) 16 (34.8) 27.0 (29.7)
No 34 (75.6) 30 (65.2) 64.0(70.3)
Anemia Total N = 100
Mild 40 (80.0) 31 (62.0) 71.0 (71.0)
Moderate 10 (20.0)) 19 (38.0) 29.0(29.0)
https://doi.org/10.1371/journal.pone.0239192.t005
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was significantly higher in the amaranth arm as compared with maize arm. Also the risk of
anemia was significantly lower in the amaranth arm as compared with maize arm. There is
currently no extant literature in the study area examining the effect of processed amaranth
grain on anemia status to which our results can be compared. However, one study conducted
on amaranth leaf in Ghana showed similar result to this study. Amaranth leaf dried powder
had a significant effect on anemia prevalence. Specifically, anemia prevalence decreased by
28% and hemoglobin concentrations were higher by 8.9 g/L after using amaranth leaf powder
[10]. The presence of micronutrients other than iron in the amaranth grain, such as folic acid,
copper, and vitamin A may have contributed to the increased hemoglobin [22–24], but
changes in those levels were not quantified either in that study or the present one.
In contrast, a study conducted in Kenya demonstrated that amaranth did not decrease ane-
mia prevalence significantly [6]. But the study used raw/unprocessed amaranth grain, which is
high in phytate, and suggested that reducing the phytate level of amaranth grain may contrib-
ute to increasing the hemoglobin level. It is widely recognized that phytate can impede the
absorption of iron and other micro- and macro-nutrients from the gut. This problem can be
resolved, however, by applying homemade processing, such as soaking, germinating, and fer-
menting [8,9]. Therefore, we believe that the result obtained in this study was related with
homemade processing applied to amaranth grain that decreased the phytate level and
enhanced the absorption of iron and other micro- and macro-nutrients.
Iron deficiency anemia is significantly decreased in the amaranth group in the last follow
up measure in the intention to treat analysis. But the change was not significant in the com-
plete case analysis. This difference may be due to the presence of higher inflammation at base-
line, confirmed by high CRP level in both arms when compared with last follow up. This is
supported by other studies reporting that CRP and ferritin have a positive correlation [25].
This means some of the ferritin level observed as normal at baseline measure may related with
Table 6. The mean dietary diversity score of 24 hours recall.
Month Group Dietary diversity mean score (CI) Mean Difference (CI) P-value
1 Maize 2.5 (2.6–2.2) -0.24 (-.82;.33) 0.4
Amaranth 2.8 (2.3–3.3) -0.24 (-.82;.33) 0.4
2 Maize 2.5 (2.1–2.9) -0.39 (-1.15;.36) 0.3
Amaranth 3.1 (2.5–3.7) -0.39 (-1.15;.36) 0.3
3 Maize 2.8 (2.4–3.2) -0.49 (-1.19;.21) 0.2
Amaranth 3.2 (2.6–3.7) -0.49 (-1.19;0.21) 0.2
4 Maize 2.9 (2.4–3.3) -0.04 (-0.66;0.58) 0.8
Amaranth 2.8 (2.3–3.2) -0.04 (-0.66–0.58) 0.8
5 Maize 2.9 (2.4–3.4) -0.31 (-1.01–0.38) 0.4
Amaranth 3.1 (2.6–3.6) -0.31 (-1.01–0.38) 0.4
6 Maize 3.4 (2.9–3.9) -0.26 (-0.94–0.41) 0.4
Amaranth 3.6 (3.2–4.1) -0.27 (-0.94–0.41) 0.4
https://doi.org/10.1371/journal.pone.0239192.t006
Table 7. Seven days iron-rich food frequency recall of six consecutive months follow-up.
Cumulative Frequency Maize Amaranth Total P-value
0 27 (65.9) 22 (53.7) 49 (59.8) 0.7
1 8 (19.5) 9 (22.0) 17 (20.7)
2 4 (9.8) 6 (14.6) 10 (12.2)
3 2 (4.9) 4 (9.8) 6 (7.3)
https://doi.org/10.1371/journal.pone.0239192.t007
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the presence of inflammation. We adjusted ferritin with CRP level but this may not control the
false reading of ferritin by hundred percent [26]. This condition may prevent discernment of
the precise effect of amaranth on ferritin level or iron deficiency anemia. In the future, larger
sample size and inclusion of additional iron indicator tests may provide more information on
the iron status of children [26].
The last follow up measure indicated that anemia prevalence was noticeably decreased in
the maize group, as well. This may be attributable to a reduction of helminth burden due to
albendazole given to both arms. This result also supported by research conducted on the effect
of deworming on anemia prevalence [27,28]. Furthermore, the daily supervision of a bread
provider at the household level may have created awareness of sanitation and child-feeding
practices, which in turn may have had a positive impact by decreasing the incidence of inflam-
mation and improved dietary diversity. The fermented maize bread itself may also have
increased the intake of iron and other micro and macro nutrients.
The acceptability test was not done for this particular research. However, prior to this study
a similar combination was tested for acceptability in the research area by the same author and
the result indicated the prepared food was acceptable by the community [9]. Non-acceptability
of the food was also not reported during supervision and follow-up time.
Regarding the iron intake, there were no other iron supplementation programs in the
research area. Further, we did a follow up every month for dietary diversity and iron-rich and
bioavailable food consumption such as animal product (red meat, organ meat and fish). The
six month follow up indicated that there was low consumption of iron-rich food and there was
no significant difference between groups both for dietary diversity score and iron-rich food
consumption.
Table 8. The effect of amaranth bread on anemia prevalence.
No anemia Anemia CRR (95% CI) ARR (95%CI)
Intention-to-treat analysis
Maize 22/50 (44.0) 28/50 (56.0) 1 1
Amaranth 34/50 (68.0) 16/50 (32.0) 0.57 (0.35–0.92) 0.39 (0.16–0.77)
Complete-case analysis
Maize 22/41 (53.7) 19/41 (46.3) 1 1
Amaranth 34/41 (82.9) 7/41 (17.1) 0.37 (0.17–0.78) 0.18 (0.05–0.57)
CRR, crude relative risk; ARR, adjusted relative risk; CI, confidence interval; Adjusted for child age, child sex, and child nutritional status, height for age, dietary
diversity. For the intention-to-treat analysis, all missing outcomes were treated as a failure (i.e., considered as anemic without knowing their status). For the complete-
case analysis, only individuals with outcome data available were included.
https://doi.org/10.1371/journal.pone.0239192.t008
Table 9. The effect of amaranth bread on hemoglobin concentration.
Baseline mean Hemoglobin g/L Last follow up mean Hemoglobin g/L Estimated of beta coefficient (CI) P-value
Complete case analysis
Maize 103.5 (100.9–106.0) 110.1 (106.9–113.2) 1
Amaranth 101.3 (98.7–103.9) 116.2 (112.1–120.3) 8.9 (3.5–14.3) 0.003
Intention to treat analysis
Maize 103.7 (101.5–105.8) 109.1 (106.4–111.8) 1
Amaranth 101.0 (98.7–103.4) 113.3 (109.4–117.1) 7.0 (2.1–12.0) 0.006
Hemoglobin was adjusted for time, sex, age, and nutritional status (height for age).
CI: confidence interval; estimated beta coefficient, CI, and P-value analyzed using the GEE linear model.
https://doi.org/10.1371/journal.pone.0239192.t009
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Strengths and limitations of the study
This study used a simple random method to identify the study participants and cluster ran-
domization to allocate anemic children into the two arms, so that the results obtained in this
research can be reproducible if performed in a similar manner. The bread maker, bread dis-
tributor, caregivers, and data collectors were unaware of the maize or amaranth bread alloca-
tions. The caregivers fed their children daily under direct supervision. Flour blending was
performed carefully considering the ratio of amaranth, and the ratio and size of the bread were
checked regularly by a trained supervisor.
This study does not assessed other nutrient-related anemia, such as folic acid deficiency, vita-
min A deficiency, and copper deficiency as well as does not considered genetic related hemoglo-
bin disorder even though it is not common in our setup. Further we didn’t measured AGP (a-
1-acid glycoprotein) concentration to adjust ferritin. In addition, we did not conducted malaria
test and stool examination The sample size for the survey was established when individual ran-
domization was planned; however, during the survey period, we understood that children with
anemia sparsely distributed and we clustered them by geographical location to effectively manage
home based feeding and supervision, and thus clustering was not taken into account during sam-
ple size calculations however we managed during analysis using intra class correlation coefficient.
Conclusion
The consumption of processed amaranth-containing bread decreased anemia prevalence,
increased mean hemoglobin concentration, and minimized iron deficiency anemia prevalence
Table 10. The effect of amaranth bread on iron deficiency anemia.
Baseline Last measurement Adjusted relative risk ratio (95% CI)
Iron deficiency anemia Iron deficiency anemia
Complete case analysis N = 76 No Yes No Yes
Maize 30 (78.9) 8 (21.1 30 (78.9) 8 (21.1) 1
Amaranth 25 (65.8) 13 (34.2) 31 (81.6) 7 (18.4) 0.54 (0.28–1.03)
ITT analysis N = 91
Maize 34 (75.6) 11 (24.4) 35 (77.8) 10 (22.2) 1
Amaranth 30 (65.2) 16 (34.8) 39 (84.8) 7 (15.5) 0.44 (0.23–0.83)�
CI: confidence interval; relative risk ratio, CI, and P-value analyzed using the GEE binomial model. Iron deficiency anemia was adjusted for time, sex, age, dietary
diversity and nutritional status (height for age).
https://doi.org/10.1371/journal.pone.0239192.t010
Table 11. Iron deficiency distribution between groups at baseline and at last follow-up measure.
Intervention group Iron deficiency Baseline Iron deficiency last follow up Relative risk (95%CI)
Yes No Yes No
Complete case analysis N = 76
Maize 8 (21.1)) 30 (78.9) 9 (23.7) 29 (76.3) 1
Amaranth 13 (34.2) 25 (65.8) 10 (26.3) 28 (73.7) 1.12 (0.81–1.55)
Intention to treat analysis N = 91
Maize 11 (24.4) 34 (75.6) 12 (26.7) 33 (73.3) 1
Amaranth 16 (34.8) 30 (65.2) 13 (28.3) 33 (71.7) 0.81 (0.55–1.19)
CI: confidence interval; relative risk ration and CI; analyzed using the GEE binomial model. Iron deficiency were adjusted for time, sex, age, dietary diversity and
nutritional status (height for age).
https://doi.org/10.1371/journal.pone.0239192.t011
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of the participated children. Therefore, processed amaranth grain bread has the potential to
minimize the prevalence of anemia.
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